Discontinuation of etanercept after successful treatment in patients with juvenile idiopathic arthritis

J Rheumatol. 2010 Sep;37(9):1970-1. doi: 10.3899/jrheum.100219.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Juvenile / drug therapy*
  • Child
  • Child, Preschool
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Remission Induction
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept